PR94097

FLORENCE, Italy, Jan. 17, 2022 /PRNewswire=KYODO JBN/ --

The new Omicron variant is spreading rapidly causing an increase in infections

at unprecedented speed. On November 28th, WHO officially recommended

laboratories to use Real Time PCR detection kits capable of identifying

putative Omicron variant infections, directly at the moment of the positivity

test.

To support this recommendation, Menarini offers CoronaMeltVAR, a CE-IVD

Real-Time PCR kit based on intercalating dye and melting curve analysis. The

kit detects positive samples with high sensitivity, through the amplification

of two targets, both compatible with all variants and with the wild type form,

simultaneously revealing with distinct signals the suspect presence of Omicron

Variant BA.1, BA.2, as well as Alpha, Beta/Gamma and WT/Delta.

All responses are obtained in a single run on each sample, with no loss of

sensitivity compared to normal kits and without the need to perform a second

reflex test on positive samples. The kit is compatible with most RNA extraction

protocols and Real-Time PCR instruments capable of performing melting curve

analysis at moderate resolution. CoronaMeltVAR provides SARS CoV-2 CE IVD

detection and Omicron surveillance in less than 2 hours.

"We are extremely proud to have made this unique solution available so quickly.

It is helping healthcare professionals in providing a specific, rapid and

accurate solution for the diagnosis and identification of Covid-19 Omicron

variant", said Fabio Piazzalunga, General Manager & Global Head of A.Menarini

Diagnostics and Chairman/CEO of Menarini Silicon Biosystems.

A.Menarini Diagnostics, the Human Touch of Technology: more than 35 years

dedicated to helping healthcare professionals make safe and sustainable

diagnosis, improving the quality of life of people all over the world.

A.Menarini Diagnostics is part of the Menarini Pharmaceutical Group, founded in

1886. Today it is present in 140 countries throughout the world, it counts more

than 17,000 employees and has a 2020 turnover of € 3.750 billion.

www.menarinidiagnostics.com　

Logo - https://mma.prnewswire.com/media/1584634/Menarini_Logo.jpg

Source: Menarini Industrie Farmaceutiche Riunite